MoneyWorks4Me

Mankind Pharma - Quaterly Results

15 May 2024 Evaluate
The revenue zoomed 14.99% to Rs. 21526.87 millions for the quarter ended March 2024 as compared to Rs. 18721.22 millions during the corresponding quarter last year.Handsome Net Profit growth of 61.63% reported above the corresponding previous quarter figure of Rs. 4541.70 millions to Rs. 2809.88 millions.Operating profit for the quarter ended March 2024 rose to 6311.87 millions as compared to 4236.17 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 21526.87 18721.22 14.99 92648.09 81271.53 14.00 92648.09 81271.53 14.00
Other Income 838.54 424.55 97.51 2666.38 1627.83 63.80 2666.38 1627.83 63.80
PBIDT 6311.87 4236.17 49.00 25917.44 18601.65 39.33 25917.44 18601.65 39.33
Interest 40.34 8.85 355.82 145.70 277.48 -47.49 145.70 277.48 -47.49
PBDT 6271.53 4227.32 48.36 25771.74 18324.17 40.64 25771.74 18324.17 40.64
Depreciation 822.93 672.98 22.28 3176.06 2695.80 17.82 3176.06 2695.80 17.82
PBT 5448.60 3554.34 53.29 22595.68 15628.37 44.58 22595.68 15628.37 44.58
TAX 906.90 744.46 21.82 4361.57 3145.79 38.65 4361.57 3145.79 38.65
Deferred Tax -199.64 -64.48 209.62 195.98 229.43 -14.58 195.98 229.43 -14.58
PAT 4541.70 2809.88 61.63 18234.11 12482.58 46.08 18234.11 12482.58 46.08
Equity 400.59 400.59 0.00 400.59 400.59 0.00 400.59 400.59 0.00
PBIDTM(%) 29.32 22.63 29.58 27.97 22.89 22.22 27.97 22.89 22.22
Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..